Herrera-Hidalgo, L.; Luque-Márquez, R.; de Alarcon, A.; Guisado-Gil, A.B.; Gutierrez-Gutierrez, B.; Navarro-Amuedo, M.D.; Praena-Segovia, J.; Carmona-Caballero, J.M.; Fraile-Ramos, E.; Gutierrez-Valencia, A.;
et al. Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT. J. Clin. Med. 2022, 11, 1551.
https://doi.org/10.3390/jcm11061551
AMA Style
Herrera-Hidalgo L, Luque-Márquez R, de Alarcon A, Guisado-Gil AB, Gutierrez-Gutierrez B, Navarro-Amuedo MD, Praena-Segovia J, Carmona-Caballero JM, Fraile-Ramos E, Gutierrez-Valencia A,
et al. Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT. Journal of Clinical Medicine. 2022; 11(6):1551.
https://doi.org/10.3390/jcm11061551
Chicago/Turabian Style
Herrera-Hidalgo, Laura, Rafael Luque-Márquez, Aristides de Alarcon, Ana Belén Guisado-Gil, Belen Gutierrez-Gutierrez, Maria Dolores Navarro-Amuedo, Julia Praena-Segovia, Juan Manuel Carmona-Caballero, Elena Fraile-Ramos, Alicia Gutierrez-Valencia,
and et al. 2022. "Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT" Journal of Clinical Medicine 11, no. 6: 1551.
https://doi.org/10.3390/jcm11061551
APA Style
Herrera-Hidalgo, L., Luque-Márquez, R., de Alarcon, A., Guisado-Gil, A. B., Gutierrez-Gutierrez, B., Navarro-Amuedo, M. D., Praena-Segovia, J., Carmona-Caballero, J. M., Fraile-Ramos, E., Gutierrez-Valencia, A., Lopez-Cortes, L. E., & Gil-Navarro, M. V.
(2022). Clinical Outcomes of an Innovative Cefazolin Delivery Program for MSSA Infections in OPAT. Journal of Clinical Medicine, 11(6), 1551.
https://doi.org/10.3390/jcm11061551
